Raras
Buscar doenças, sintomas, genes...
Miopatia distal
ORPHA:599CID-11 · 8C75DOENÇA RARA

Miopatia distal é um grupo de doenças dos músculos que têm como característica principal a perda de força e a diminuição (atrofia) dos músculos, começando nos pés e/ou nas mãos.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Miopatia distal é um grupo de doenças dos músculos que têm como característica principal a perda de força e a diminuição (atrofia) dos músculos, começando nos pés e/ou nas mãos.

Pesquisas ativas
1 ensaio
22 total registrados no ClinicalTrials.gov
Publicações científicas
774 artigos
Último publicado: 2026 Mar
Medicamentos
1 registrados
DEFLAZACORT

Tem tratamento?

1 medicamento registrado
Ver detalhes, fases e interações →
DEFLAZACORT

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.33
United Kingdom
Início
All ages
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

💪
Músculos
95 sintomas
🧠
Neurológico
16 sintomas
🦴
Ossos e articulações
15 sintomas
🫁
Pulmão
8 sintomas
❤️
Coração
8 sintomas
😀
Face
7 sintomas

+ 87 sintomas em outras categorias

Características mais comuns

Cisão de fibra muscular
Anormalidade do músculo masseter
Amiotrofia do membro superior
Parkinsonismo
Ansiedade
Depressão
255sintomas
Sem dados (255)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 255 características clínicas mais associadas, ordenadas por frequência.

Cisão de fibra muscularMuscle fiber splitting
Anormalidade do músculo masseterAbnormality of masseter muscle
Amiotrofia do membro superiorUpper limb amyotrophy
ParkinsonismoParkinsonism
AnsiedadeAnxiety

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico774PubMed
Últimos 10 anos200publicações
Pico202446 papers
Linha do tempo
2026Hoje · 2026🧪 2005Primeiro ensaio clínico📈 2024Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

24 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive.

DYSFDysferlinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Key calcium ion sensor involved in the Ca(2+)-triggered synaptic vesicle-plasma membrane fusion. Plays a role in the sarcolemma repair mechanism of both skeletal muscle and cardiomyocytes that permits rapid resealing of membranes disrupted by mechanical stress (By similarity)

LOCALIZAÇÃO

Cell membrane, sarcolemmaCytoplasmic vesicle membraneCell membraneLate endosome membrane

VIAS BIOLÓGICAS (1)
Smooth Muscle Contraction
MECANISMO DE DOENÇA

Muscular dystrophy, limb-girdle, autosomal recessive 2

An autosomal recessive degenerative myopathy characterized by weakness and atrophy starting in the proximal pelvifemoral muscles, with onset in the late teens or later, massive elevation of serum creatine kinase levels and slow progression. Scapular muscle involvement is minor and not present at onset. Upper limb girdle involvement follows some years after the onset in lower limbs.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
164.1 TPM
Baço
67.3 TPM
Músculo esquelético
44.4 TPM
Pulmão
30.5 TPM
Cólon sigmoide
23.4 TPM
OUTRAS DOENÇAS (6)
autosomal recessive limb-girdle muscular dystrophy type 2Bdistal myopathy with anterior tibial onsetMiyoshi muscular dystrophy 1autosomal recessive limb-girdle muscular dystrophy
HGNC:3097UniProt:O75923
NEBNebulinCandidate gene tested inRestrito
FUNÇÃO

This giant muscle protein may be involved in maintaining the structural integrity of sarcomeres and the membrane system associated with the myofibrils. Binds and stabilize F-actin

LOCALIZAÇÃO

Cytoplasm, myofibril, sarcomereCytoplasm, cytoskeleton

VIAS BIOLÓGICAS (1)
Striated Muscle Contraction
MECANISMO DE DOENÇA

Nemaline myopathy 2

A form of nemaline myopathy. Nemaline myopathies are muscular disorders characterized by muscle weakness of varying severity and onset, and abnormal thread-like or rod-shaped structures in muscle fibers on histologic examination.

EXPRESSÃO TECIDUAL(Tecido-específico)
Músculo esquelético
846.4 TPM
Coração - Átrio
4.5 TPM
Glândula salivar
1.5 TPM
Skin Not Sun Exposed Suprapubic
1.1 TPM
Skin Sun Exposed Lower leg
1.1 TPM
OUTRAS DOENÇAS (9)
arthrogryposis multiplex congenita 6nemaline myopathynemaline myopathy 2typical nemaline myopathy
HGNC:7720UniProt:P20929
NUTM2B-AS1Candidate gene tested inDesconhecido
LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
Formation of definitive endoderm
OUTRAS DOENÇAS (2)
oculopharyngeal myopathy with leukoencephalopathy 1oculopharyngodistal myopathy
HGNC:51204
VCPTransitional endoplasmic reticulum ATPaseCandidate gene tested inAltamente restrito
FUNÇÃO

Necessary for the fragmentation of Golgi stacks during mitosis and for their reassembly after mitosis. Involved in the formation of the transitional endoplasmic reticulum (tER). The transfer of membranes from the endoplasmic reticulum to the Golgi apparatus occurs via 50-70 nm transition vesicles which derive from part-rough, part-smooth transitional elements of the endoplasmic reticulum (tER). Vesicle budding from the tER is an ATP-dependent process. The ternary complex containing UFD1, VCP and

LOCALIZAÇÃO

Cytoplasm, cytosolEndoplasmic reticulumNucleusCytoplasm, Stress granule

VIAS BIOLÓGICAS (10)
AggrephagyAttachment and EntryAttachment and EntryAMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274)ABC-family proteins mediated transport
MECANISMO DE DOENÇA

Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1

An autosomal dominant disease characterized by disabling muscle weakness clinically resembling to limb girdle muscular dystrophy, osteolytic bone lesions consistent with Paget disease, and premature frontotemporal dementia. Clinical features show incomplete penetrance.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
229.2 TPM
Linfócitos
209.1 TPM
Músculo esquelético
193.2 TPM
Aorta
172.4 TPM
Útero
171.2 TPM
OUTRAS DOENÇAS (10)
frontotemporal dementia and/or amyotrophic lateral sclerosis 6inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1Charcot-Marie-Tooth disease type 2Yamyotrophic lateral sclerosis
HGNC:12666UniProt:P55072
KLHL9Kelch-like protein 9Candidate gene tested inTolerante
FUNÇÃO

Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex required for mitotic progression and cytokinesis. The BCR(KLHL9-KLHL13) E3 ubiquitin ligase complex mediates the ubiquitination of AURKB and controls the dynamic behavior of AURKB on mitotic chromosomes and thereby coordinates faithful mitotic progression and completion of cytokinesis

LOCALIZAÇÃO

VIAS BIOLÓGICAS (2)
Antigen processing: Ubiquitination & Proteasome degradationNeddylation
EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
38.0 TPM
Linfócitos
31.7 TPM
Útero
22.7 TPM
Cervix Endocervix
22.5 TPM
Nervo tibial
21.8 TPM
OUTRAS DOENÇAS (1)
KLHL9-related early-onset distal myopathy
HGNC:18732UniProt:Q9P2J3
MATR3Matrin-3Candidate gene tested inAltamente restrito
FUNÇÃO

May play a role in transcription or may interact with other nuclear matrix proteins to form the internal fibrogranular network. In association with the SFPQ-NONO heteromer may play a role in nuclear retention of defective RNAs. Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (PubMed:2871272

LOCALIZAÇÃO

Nucleus matrix

MECANISMO DE DOENÇA

Amyotrophic lateral sclerosis 21

A neurodegenerative disorder affecting upper and lower motor neurons, resulting in muscle weakness and respiratory failure. Some patients may develop myopathic features or dementia.

OUTRAS DOENÇAS (3)
amyotrophic lateral sclerosis type 21distal myopathy with vocal cord weaknessamyotrophic lateral sclerosis
HGNC:6912UniProt:P43243
ABCD3ATP-binding cassette sub-family D member 3Candidate gene tested inRestrito
FUNÇÃO

Broad substrate specificity ATP-dependent transporter of the ATP-binding cassette (ABC) family that catalyzes the transport of long-chain fatty acids (LCFA)-CoA, dicarboxylic acids-CoA, long-branched-chain fatty acids-CoA and bile acids from the cytosol to the peroxisome lumen for beta-oxydation (PubMed:11248239, PubMed:24333844, PubMed:25168382, PubMed:29397936). Has fatty acyl-CoA thioesterase and ATPase activities (PubMed:29397936). Probably hydrolyzes fatty acyl-CoAs into free fatty acids pr

LOCALIZAÇÃO

Peroxisome membrane

VIAS BIOLÓGICAS (2)
ABC transporters in lipid homeostasisClass I peroxisomal membrane protein import
MECANISMO DE DOENÇA

Congenital bile acid synthesis defect 5

An autosomal recessive disorder characterized by hepatosplenomegaly, hepatic fibrosis, progressive liver failure, and accumulation of peroxisomal C27-bile acid intermediates in plasma.

OUTRAS DOENÇAS (2)
congenital bile acid synthesis defect 5oculopharyngodistal myopathy
HGNC:67UniProt:P28288
ADSS1Adenylosuccinate synthetase isozyme 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the purine nucleotide cycle (PNC), which interconverts IMP and AMP to regulate the nucleotide levels in various tissues, and which contributes to glycolysis and ammoniagenesis. Catalyzes the first committed step in the biosynthesis of AMP from IMP

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (1)
Purine ribonucleoside monophosphate biosynthesis
MECANISMO DE DOENÇA

Myopathy, distal, 5

A form of distal myopathy, a group of muscular disorders characterized by progressive muscular weakness and muscle atrophy beginning in the hands, the legs or the feet. MPD5 is an autosomal recessive form, predominantly affecting the lower limbs.

OUTRAS DOENÇAS (1)
myopathy, distal, 5
HGNC:20093UniProt:Q8N142
ANO5Anoctamin-5Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in plasma membrane repair in a process involving annexins (PubMed:33496727). Does not exhibit calcium-activated chloride channel (CaCC) activity

LOCALIZAÇÃO

Endoplasmic reticulum membraneCell membrane

VIAS BIOLÓGICAS (2)
Induction of Cell-Cell FusionStimuli-sensing channels
MECANISMO DE DOENÇA

Gnathodiaphyseal dysplasia

Rare skeletal syndrome characterized by bone fragility, sclerosis of tubular bones, and cemento-osseous lesions of the jawbone. Patients experience frequent bone fractures caused by trivial accidents in childhood; however the fractures heal normally without bone deformity. The jaw lesions replace the tooth-bearing segments of the maxilla and mandible with fibrous connective tissues, including various amounts of cementum-like calcified mass, sometimes causing facial deformities. Patients also have a propensity for jaw infection and often suffer from purulent osteomyelitis-like symptoms, such as swelling of and pus discharge from the gums, mobility of the teeth, insufficient healing after tooth extraction and exposure of the lesions into the oral cavity.

OUTRAS DOENÇAS (6)
autosomal recessive limb-girdle muscular dystrophy type 2Lgnathodiaphyseal dysplasiaautosomal recessive limb-girdle muscular dystrophyMiyoshi muscular dystrophy 3
HGNC:27337UniProt:Q75V66
HNRNPA1Heterogeneous nuclear ribonucleoprotein A1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Involved in the packaging of pre-mRNA into hnRNP particles, transport of poly(A) mRNA from the nucleus to the cytoplasm and modulation of splice site selection (PubMed:17371836). Plays a role in the splicing of pyruvate kinase PKM by binding repressively to sequences flanking PKM exon 9, inhibiting exon 9 inclusion and resulting in exon 10 inclusion and production of the PKM M2 isoform (PubMed:20010808). Binds to the IRES and thereby inhibits the translation of the apoptosis protease activating

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (5)
FGFR2 alternative splicingmRNA Splicing - Major PathwaymRNA PolyadenylationProcessing of Capped Intron-Containing Pre-mRNADengue Virus-Host Interactions
MECANISMO DE DOENÇA

Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3

An autosomal dominant disease characterized by disabling muscle weakness clinically resembling to limb girdle muscular dystrophy, osteolytic bone lesions consistent with Paget disease, and premature frontotemporal dementia. Clinical features show incomplete penetrance.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
1092.5 TPM
Linfócitos
728.9 TPM
Cervix Ectocervix
629.5 TPM
Cervix Endocervix
629.4 TPM
Útero
591.7 TPM
OUTRAS DOENÇAS (5)
inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3amyotrophic lateral sclerosis type 20Finnish upper limb-onset distal myopathyamyotrophic lateral sclerosis
HGNC:5031UniProt:P09651
TIA1Cytotoxic granule associated RNA binding protein TIA1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

RNA-binding protein involved in the regulation of alternative pre-RNA splicing and mRNA translation by binding to uridine-rich (U-rich) RNA sequences (PubMed:11106748, PubMed:12486009, PubMed:17488725, PubMed:8576255). Binds to U-rich sequences immediately downstream from a 5' splice sites in a uridine-rich small nuclear ribonucleoprotein (U snRNP)-dependent fashion, thereby modulating alternative pre-RNA splicing (PubMed:11106748, PubMed:8576255). Preferably binds to the U-rich IAS1 sequence in

LOCALIZAÇÃO

NucleusCytoplasmCytoplasm, Stress granule

VIAS BIOLÓGICAS (1)
FGFR2 alternative splicing
MECANISMO DE DOENÇA

Welander distal myopathy

An autosomal dominant disorder characterized by adult onset of distal muscle weakness predominantly affecting the distal long extensors of the hands, with slow progression to involve all small hand muscles and the lower legs. Skeletal muscle biopsy shows myopathic changes and prominent rimmed vacuoles. Rare homozygous patients showed earlier onset, faster progression, and proximal muscle involvement.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
112.7 TPM
Cervix Endocervix
105.2 TPM
Útero
102.6 TPM
Cervix Ectocervix
100.3 TPM
Fallopian Tube
98.5 TPM
OUTRAS DOENÇAS (2)
distal myopathy, Welander typeamyotrophic lateral sclerosis 26 with or without frontotemporal dementia
HGNC:11802UniProt:P31483
RILPL1RILP-like protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in the regulation of cell shape and polarity (By similarity). Plays a role in cellular protein transport, including protein transport away from primary cilia (By similarity). Neuroprotective protein, which acts by sequestring GAPDH in the cytosol and prevent the apoptotic function of GAPDH in the nucleus (By similarity). Competes with SIAH1 for binding GAPDH (By similarity). Does not regulate lysosomal morphology and distribution (PubMed:14668488). Binds to RAB10 following LRRK2-med

LOCALIZAÇÃO

Cytoplasm, cytosolCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centrioleCytoplasm, cytoskeleton, cilium basal body

MECANISMO DE DOENÇA

Oculopharyngodistal myopathy 4

A form of oculopharyngodistal myopathy, a muscle disorder characterized by progressive ptosis, external ophthalmoplegia, and weakness of the masseter, facial, pharyngeal, and distal limb muscles. The myopathological features are presence of rimmed vacuoles in the muscle fibers and myopathic changes of differing severity. OPDM4 is an autosomal dominant form characterized by slow progression and onset of symptoms in the second or third decades.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Átrio
27.2 TPM
Aorta
22.7 TPM
Coração - Ventrículo esquerdo
19.9 TPM
Músculo esquelético
19.7 TPM
Tireoide
19.6 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
oculopharyngodistal myopathy 4oculopharyngodistal myopathy
HGNC:26814UniProt:Q5EBL4
FLNCFilamin-CDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Muscle-specific filamin, which plays a central role in sarcomere assembly and organization (PubMed:34405687). Critical for normal myogenesis, it probably functions as a large actin-cross-linking protein with structural functions at the Z lines in muscle cells. May be involved in reorganizing the actin cytoskeleton in response to signaling events (By similarity)

LOCALIZAÇÃO

CytoplasmMembraneCytoplasm, cytoskeletonCytoplasm, myofibril, sarcomere, Z line

VIAS BIOLÓGICAS (1)
Cell-extracellular matrix interactions
MECANISMO DE DOENÇA

Myopathy, myofibrillar, 5

A form of myofibrillar myopathy, a group of chronic neuromuscular disorders characterized at ultrastructural level by disintegration of the sarcomeric Z disk and myofibrils, and replacement of the normal myofibrillar markings by small dense granules, or larger hyaline masses, or amorphous material. MFM5 is characterized by onset in adulthood, clinical features of a limb-girdle myopathy, and focal myofibrillar destruction.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
996.8 TPM
Cólon sigmoide
375.8 TPM
Esôfago - Muscular
300.4 TPM
Coração - Ventrículo esquerdo
291.6 TPM
Esôfago - Junção
246.6 TPM
OUTRAS DOENÇAS (4)
myofibrillar myopathy 5hypertrophic cardiomyopathy 26distal myopathy with posterior leg and anterior hand involvementobsolete familial isolated restrictive cardiomyopathy
HGNC:3756UniProt:Q14315
MYOTMyotilinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of a complex of multiple actin cross-linking proteins. Involved in the control of myofibril assembly and stability at the Z lines in muscle cells

LOCALIZAÇÃO

Cell membrane, sarcolemmaCytoplasm, cytoskeletonCytoplasm, myofibril, sarcomere, Z line

MECANISMO DE DOENÇA

Myopathy, myofibrillar, 3

A form of myofibrillar myopathy, a group of chronic neuromuscular disorders characterized at ultrastructural level by disintegration of the sarcomeric Z disk and myofibrils, and replacement of the normal myofibrillar markings by small dense granules, or larger hyaline masses, or amorphous material. MFM3 is characterized by progressive skeletal muscle weakness greater distally than proximally, tight heel cords, hyporeflexia, cardiomyopathy and peripheral neuropathy in some patients. Affected muscle exhibits disorganization and streaming of the Z-line, presence of large hyaline structures, excessive accumulation of myotilin and other ectopically expressed proteins and prominent congophilic deposits.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
602.6 TPM
Nervo tibial
12.9 TPM
Cólon sigmoide
10.7 TPM
Cervix Ectocervix
9.3 TPM
Esôfago - Muscular
9.1 TPM
OUTRAS DOENÇAS (1)
myofibrillar myopathy 3
HGNC:12399UniProt:Q9UBF9
SMPXSmall muscular proteinDisease-causing germline mutation(s) inModerado
FUNÇÃO

Plays a role in the regulatory network through which muscle cells coordinate their structural and functional states during growth, adaptation, and repair

LOCALIZAÇÃO

MECANISMO DE DOENÇA

Deafness, X-linked, 4

A non-syndromic form of sensorineural, progressive hearing loss with postlingual onset. In affected males, the auditory impairment affects initially high-frequency hearing. It later evolves to become severe to profound and affects all frequencies. Carrier females manifest moderate hearing impairment in the high frequencies.

EXPRESSÃO TECIDUAL(Tecido-específico)
Coração - Ventrículo esquerdo
328.9 TPM
Músculo esquelético
278.1 TPM
Coração - Átrio
272.3 TPM
Cólon sigmoide
32.5 TPM
Esôfago - Muscular
21.3 TPM
OUTRAS DOENÇAS (3)
myopathy, distal, 7, adult-onset, X-linkedhearing loss, X-linked 4X-linked nonsyndromic hearing loss
HGNC:11122UniProt:Q9UHP9
TTNTitinDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Key component in the assembly and functioning of vertebrate striated muscles. By providing connections at the level of individual microfilaments, it contributes to the fine balance of forces between the two halves of the sarcomere. The size and extensibility of the cross-links are the main determinants of sarcomere extensibility properties of muscle. In non-muscle cells, seems to play a role in chromosome condensation and chromosome segregation during mitosis. Might link the lamina network to ch

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (1)
Platelet degranulation
MECANISMO DE DOENÇA

Myopathy, myofibrillar, 9, with early respiratory failure

An autosomal dominant myopathy characterized by adulthood onset of weakness in proximal, distal, axial and respiratory muscles. Pelvic girdle weakness, foot drop and neck weakness are the main symptoms at onset, but ultimately the weakness usually involves the proximal compartment of both upper and lower limbs. Additional features include variable degrees of Achilles tendon contractures, spinal rigidity and muscle hypertrophy. Respiratory involvement often leads to requirement for non-invasive ventilation support.

EXPRESSÃO TECIDUAL(Tecido-específico)
Músculo esquelético
358.5 TPM
Coração - Ventrículo esquerdo
66.8 TPM
Coração - Átrio
56.9 TPM
Testículo
1.6 TPM
Pulmão
1.0 TPM
OUTRAS DOENÇAS (14)
autosomal recessive limb-girdle muscular dystrophy type 2Jmyopathy, myofibrillar, 9, with early respiratory failureearly-onset myopathy with fatal cardiomyopathydilated cardiomyopathy 1G
HGNC:12403UniProt:Q8WZ42
LDB3LIM domain-binding protein 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May function as an adapter in striated muscle to couple protein kinase C-mediated signaling via its LIM domains to the cytoskeleton

LOCALIZAÇÃO

Cytoplasm, perinuclear regionCell projection, pseudopodiumCytoplasm, cytoskeletonCytoplasm, myofibril, sarcomere, Z line

MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 1C, with or without left ventricular non-compaction

A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. Cardiomyopathy dilated type 1C is associated with left ventricular non-compaction in some patients. Left ventricular non-compaction is characterized by numerous prominent trabeculations and deep intertrabecular recesses in hypertrophied and hypokinetic segments of the left ventricle.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
372.3 TPM
Músculo esquelético
338.8 TPM
Coração - Átrio
299.7 TPM
Artéria tibial
89.9 TPM
Aorta
57.8 TPM
OUTRAS DOENÇAS (7)
myofibrillar myopathy 4dilated cardiomyopathy 1Cfamilial isolated arrhythmogenic ventricular dysplasia, left dominant formfamilial isolated arrhythmogenic ventricular dysplasia, biventricular form
HGNC:15710UniProt:O75112
CRYABAlpha-crystallin B chainDisease-causing germline mutation(s) inTolerante
FUNÇÃO

May contribute to the transparency and refractive index of the lens. Has chaperone-like activity, preventing aggregation of various proteins under a wide range of stress conditions. In lens epithelial cells, stabilizes the ATP6V1A protein, preventing its degradation by the proteasome (By similarity)

LOCALIZAÇÃO

CytoplasmNucleusSecretedLysosome

VIAS BIOLÓGICAS (1)
HSF1-dependent transactivation
MECANISMO DE DOENÇA

Myopathy, myofibrillar, 2A, adult-onset

A form of myofibrillar myopathy, a group of chronic neuromuscular disorders characterized at ultrastructural level by disintegration of the sarcomeric Z disk and myofibrils, and replacement of the normal myofibrillar markings by small dense granules, or larger hyaline masses, or amorphous material. MFM2A is an autosomal dominant form characterized by weakness of the proximal and distal limb muscles, weakness of the neck, velopharynx and trunk muscles, respiratory insufficiency, hypertrophic cardiomyopathy, and cataract.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
1863.3 TPM
Brain Spinal cord cervical c-1
1663.2 TPM
Coração - Átrio
1591.1 TPM
Músculo esquelético
1435.1 TPM
Nervo tibial
1093.8 TPM
OUTRAS DOENÇAS (8)
fatal infantile hypertonic myofibrillar myopathymyofibrillar myopathy 2dilated cardiomyopathy 1IIcataract 16 multiple types
HGNC:2389UniProt:P02511
GIPC1PDZ domain-containing protein GIPC1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May be involved in G protein-linked signaling

LOCALIZAÇÃO

CytoplasmMembrane

VIAS BIOLÓGICAS (4)
FGFR1b ligand binding and activationFGFR1c ligand binding and activationTGFBR3 regulates FGF2 signalingTGFBR3 regulates TGF-beta signaling
MECANISMO DE DOENÇA

Oculopharyngodistal myopathy 2

A form of oculopharyngodistal myopathy, a muscle disorder characterized by progressive ptosis, external ophthalmoplegia, and weakness of the masseter, facial, pharyngeal, and distal limb muscles. The myopathological features are presence of rimmed vacuoles in the muscle fibers and myopathic changes of differing severity. OPDM2 inheritance pattern is autosomal dominant.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Mucosa
340.8 TPM
Vagina
186.9 TPM
Skin Sun Exposed Lower leg
172.1 TPM
Skin Not Sun Exposed Suprapubic
163.3 TPM
Pulmão
111.3 TPM
OUTRAS DOENÇAS (2)
oculopharyngodistal myopathy 2oculopharyngodistal myopathy
HGNC:1226UniProt:O14908
LRP12Low-density lipoprotein receptor-related protein 12Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Probable receptor, which may be involved in the internalization of lipophilic molecules and/or signal transduction. May act as a tumor suppressor

LOCALIZAÇÃO

MembraneMembrane, coated pit

VIAS BIOLÓGICAS (1)
Retinoid metabolism and transport
MECANISMO DE DOENÇA

Oculopharyngodistal myopathy 1

A form of oculopharyngodistal myopathy, a muscle disorder characterized by progressive ptosis, external ophthalmoplegia, and weakness of the masseter, facial, pharyngeal, and distal limb muscles. The myopathological features are presence of rimmed vacuoles in the muscle fibers and myopathic changes of differing severity. OPDM1 inheritance pattern is autosomal dominant.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
21.3 TPM
Útero
17.0 TPM
Artéria tibial
10.5 TPM
Fallopian Tube
10.3 TPM
Aorta
9.5 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (3)
oculopharyngodistal myopathy 1amyotrophic lateral sclerosis 28oculopharyngodistal myopathy
HGNC:31708UniProt:Q9Y561
CAV3Caveolin-3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May act as a scaffolding protein within caveolar membranes. Interacts directly with G-protein alpha subunits and can functionally regulate their activity. May also regulate voltage-gated potassium channels. Plays a role in the sarcolemma repair mechanism of both skeletal muscle and cardiomyocytes that permits rapid resealing of membranes disrupted by mechanical stress (By similarity). Mediates the recruitment of CAVIN2 and CAVIN3 proteins to the caveolae (PubMed:19262564)

LOCALIZAÇÃO

Golgi apparatus membraneCell membraneMembrane, caveolaCell membrane, sarcolemma

VIAS BIOLÓGICAS (1)
Smooth Muscle Contraction
MECANISMO DE DOENÇA

HyperCKmia

Characterized by persistent elevated levels of serum creatine kinase without muscle weakness.

OUTRAS DOENÇAS (7)
rippling muscle disease 2distal myopathy, Tateyama typelong QT syndrome 9creatine phosphokinase, elevated serum
HGNC:1529UniProt:P56539
MYH7Myosin-7Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. Forms regular bipolar thick filaments that, together with actin thin filaments, constitute the fundamental contractile unit of skeletal and cardiac muscle

LOCALIZAÇÃO

Cytoplasm, myofibrilCytoplasm, myofibril, sarcomere

MECANISMO DE DOENÇA

Cardiomyopathy, familial hypertrophic, 1

A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
4513.7 TPM
Músculo esquelético
3692.8 TPM
Coração - Átrio
592.2 TPM
Pâncreas
5.3 TPM
Hipotálamo
4.9 TPM
OUTRAS DOENÇAS (12)
MYH7-related skeletal myopathymyopathy, myosin storage, autosomal recessivedilated cardiomyopathy 1Scongenital myopathy 7A, myosin storage, autosomal dominant
HGNC:7577UniProt:P12883
NOTCH2NLCNotch homolog 2 N-terminal-like protein CDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Human-specific protein that promotes neural progenitor proliferation and evolutionary expansion of the brain neocortex by regulating the Notch signaling pathway (PubMed:29561261, PubMed:29856954, PubMed:29856955). Able to promote neural progenitor self-renewal, possibly by down-regulating neuronal differentiation genes, thereby delaying the differentiation of neuronal progenitors and leading to an overall final increase in neuronal production (PubMed:29856954). Acts by enhancing the Notch signal

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (2)
Expression of NOTCH2NL genesNOTCH2 Activation and Transmission of Signal to the Nucleus
MECANISMO DE DOENÇA

Neuronal intranuclear inclusion disease

An autosomal dominant, slowly progressive, neurodegenerative disease characterized by eosinophilic hyaline intranuclear inclusions in the central and peripheral nervous system, and also in the visceral organs. Clinical manifestations are variable and include pyramidal and extrapyramidal symptoms, cerebellar ataxia, cognitive decline and dementia, peripheral neuropathy, and autonomic dysfunction.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (4)
oculopharyngodistal myopathy 3tremor, hereditary essential, 6neuronal intranuclear inclusion diseaseoculopharyngodistal myopathy
HGNC:53924UniProt:P0DPK4
SQSTM1Sequestosome-1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Molecular adapter required for selective macroautophagy (aggrephagy) by acting as a bridge between polyubiquitinated proteins and autophagosomes (PubMed:15340068, PubMed:15953362, PubMed:16286508, PubMed:17580304, PubMed:20168092, PubMed:22017874, PubMed:22622177, PubMed:24128730, PubMed:28404643, PubMed:29343546, PubMed:29507397, PubMed:31857589, PubMed:33509017, PubMed:34471133, PubMed:34893540, PubMed:35831301, PubMed:37306101, PubMed:37802024). Promotes the recruitment of ubiquitinated cargo

LOCALIZAÇÃO

Cytoplasmic vesicle, autophagosomePreautophagosomal structureCytoplasm, cytosolNucleus, PML bodyLate endosomeLysosomeNucleusEndoplasmic reticulumCytoplasm, myofibril, sarcomere

VIAS BIOLÓGICAS (9)
PINK1-PRKN Mediated MitophagyPexophagyNF-kB is activated and signals survivalp75NTR recruits signalling complexesInterleukin-1 signaling
MECANISMO DE DOENÇA

Paget disease of bone 3

A disorder of bone remodeling characterized by increased bone turnover affecting one or more sites throughout the skeleton, primarily the axial skeleton. Osteoclastic overactivity followed by compensatory osteoblastic activity leads to a structurally disorganized mosaic of bone (woven bone), which is mechanically weaker, larger, less compact, more vascular, and more susceptible to fracture than normal adult lamellar bone.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
155.2 TPM
Artéria tibial
140.4 TPM
Aorta
135.6 TPM
Fibroblastos
134.0 TPM
Glândula adrenal
131.3 TPM
OUTRAS DOENÇAS (8)
Paget disease of bone 3myopathy, distal, with rimmed vacuolesneurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onsetfrontotemporal dementia and/or amyotrophic lateral sclerosis 3
HGNC:11280UniProt:Q13501

Medicamentos e terapias

DEFLAZACORTPhase 2

Mecanismo: Glucocorticoid receptor agonist

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

3,608 variantes patogênicas registradas no ClinVar.

🧬 DYSF: NM_001130987.2(DYSF):c.1023C>A (p.Tyr341Ter) ()
🧬 DYSF: NM_001130987.2(DYSF):c.240-2A>G ()
🧬 DYSF: NM_001130987.2(DYSF):c.4458del (p.Ile1487fs) ()
🧬 DYSF: NM_001130987.2(DYSF):c.5689del (p.Tyr1897fs) ()
🧬 DYSF: NM_001130987.2(DYSF):c.5628C>A (p.Asp1876Glu) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 5,837 variantes classificadas pelo ClinVar.

1751
4086
VUS (30.0%)
Benigna (70.0%)
VARIANTES MAIS SIGNIFICATIVAS
FLNC: NM_001458.5(FLNC):c.7739C>T (p.Pro2580Leu) [Uncertain significance]
FLNC: NM_001458.5(FLNC):c.4591A>T (p.Ile1531Phe) [Uncertain significance]
FLNC: NM_001458.5(FLNC):c.1952A>G (p.Asp651Gly) [Uncertain significance]
FLNC: NM_001458.5(FLNC):c.4580+6G>T [Uncertain significance]
FLNC: NM_001458.5(FLNC):c.6437C>T (p.Ser2146Phe) [Uncertain significance]

Vias biológicas (Reactome)

70 vias biológicas associadas aos genes desta condição.

Smooth Muscle Contraction Striated Muscle Contraction GATA6-AS1 lncRNA p-2S-SMAD2,3:GATA6-AS1 lncRNA:GATA6 gene AS160:IRAP Phospho AS160:14-3-3 p-5S,T642-AS160:IRAP p-5S,T642-AS160:14-3-3:IRAP SMAD2,3 and GATA6-AS1 lncRNA bind the GATA6 gene 14-3-3 binds p-5S,T642-AS160 (TBC1D4) p-AKT1,p-AKT2 phosphorylates AS160 (TBC1D4) CTBP1,CTBP2 binds ZEB1 CD274 mRNA binds miR-142-5p RISC Expression of GATA6 in definitive endoderm CTBP1,CTBP2 binds CDH1 gene promoter PRC2 (EZH2) core complex binds CDH1 gene promoter Translesion Synthesis by POLH HSF1 activation ABC-family proteins mediated transport N-glycan trimming in the ER and Calnexin/Calreticulin cycle Hedgehog ligand biogenesis Hh mutants are degraded by ERAD Defective CFTR causes cystic fibrosis Josephin domain DUBs Ovarian tumor domain proteases Neutrophil degranulation E3 ubiquitin ligases ubiquitinate target proteins Protein methylation Neddylation RHOH GTPase cycle Aggrephagy Attachment and Entry Attachment and Entry KEAP1-NFE2L2 pathway Dengue Virus Genome Translation and Replication AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide Antigen processing: Ubiquitination & Proteasome degradation ABC transporters in lipid homeostasis RHOA GTPase cycle RHOC GTPase cycle Class I peroxisomal membrane protein import Purine ribonucleoside monophosphate biosynthesis Stimuli-sensing channels Induction of Cell-Cell Fusion FGFR2 alternative splicing mRNA Splicing - Major Pathway Processing of Capped Intron-Containing Pre-mRNA SARS-CoV-1-host interactions SARS-CoV-1 modulates host translation machinery mRNA Polyadenylation Dengue Virus-Host Interactions Cell-extracellular matrix interactions Platelet degranulation HSF1-dependent transactivation FGFR1b ligand binding and activation FGFR1c ligand binding and activation TGFBR3 regulates TGF-beta signaling TGFBR3 regulates FGF2 signaling Retinoid metabolism and transport NOTCH2 Activation and Transmission of Signal to the Nucleus Expression of NOTCH2NL genes NRIF signals cell death from the nucleus p75NTR recruits signalling complexes NF-kB is activated and signals survival PINK1-PRKN Mediated Mitophagy Interleukin-1 signaling Pexophagy Signaling by ALK fusions and activated point mutants Nuclear events mediated by NFE2L2

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 33
2Fase 22
·Pré-clínico3
Medicamentos catalogadosEnsaios clínicos· 1 medicamento · 7 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Miopatia distal

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

22 ensaios clínicos encontrados, 1 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥈Melhor nível de evidência: Observacional
Timeline de publicações
322 papers (10 anos)
#1

Comparison of whole-body muscle imaging findings between GNE myopathy and other young adult-onset hereditary myopathies.

PloS one2026

Previous muscle imaging studies of GNE myopathy are limited to the lower extremities. This study aimed to use whole-body MRI to differentiate between GNE myopathy and other young adult-onset hereditary myopathies. This retrospective cohort study recruited patients with GNE myopathy or young adult-onset hereditary with limb girdle weakness pattern followed up in a single-center neuromuscular clinical registry between 2019 and 2023. Fatty tissue replacement was evaluated using a 5-point scale using T1-weighted images (T1WI) and proton-density fat fractions (PDFF) from mDIXON Quant images. Inflammation was evaluated using short tau inversion recovery imaging. The distribution and severity of muscle involvement in GNE myopathy were visualized using heat maps, and the parameters were tested for significance. Of 103 patients, five with GNE myopathy and 10 with young adult-onset hereditary myopathy were recruited. Prominent fatty tissue replacement was seen in specific muscles with subtle active inflammation in GNE myopathy. The comparison of fatty tissue replacement between GNE and other young adult-onset hereditary myopathies exhibited the classic quadriceps sparing pattern in GNE myopathy group. Beyond these findings, latissimus dorsi showed the significantly lower fatty tissue replacement in the GNE group (median [IQR] of T1WI grade 1 [0, 1] vs. 3 [1, 3.4], p = 0.04) and mean (± S.D.) of PDFF in mDIXON Quant (19.0 ± 9.7 vs. 42.6 ± 22.7, p = 0.04). The latissimus dorsi sparing out of proportion to periscapular weakness would be a novel differentiative feature of GNE myopathy.

#2

A heterozygous 9q34 deletion encompassing SPTAN1 as a cause of distal myopathy.

European journal of human genetics : EJHG2026 Jan

We report a family affected with childhood onset distal muscle weakness with a heterozygous chromosome 9q34 deletion encompassing the SPTAN1 gene. The deletion was detected through exome-sequencing based copy number variant (CNV) detection, segregates in four patients and is non-penetrant in two other relatives. Electromyography, muscle MRI and muscle biopsy revealed a myopathic disease phenotype. Cellular consequences of the deletion were investigated using qPCR and western blotting on patient-derived fibroblasts, which revealed a reduction of RNA but not protein levels. Immunocytochemistry was performed on muscle tissue which did not reveal reduction of α-II-spectrin. SPTAN1 loss-of-function variants have previously been reported to cause distal hereditary motor neuropathy and recently distal myopathy. Here, we confirm the role of SPTAN1 haploinsufficiency as a cause of distal myopathy. We propose an age-dependent lack of α-II-spectrin and suggest CNV detection in repurposed exome sequencing as an important diagnostic tool.

#3

Multi-Parametric MRI Approach at 3 T and 7 T for Assessing Skeletal Muscle Pathology in Myofibrillar Myopathies: A Pilot Study.

Journal of cachexia, sarcopenia and muscle2026 Apr

Myofibrillar myopathies (MFM) form a large group of clinically and genetically heterogeneous protein aggregate diseases. We investigated whether a novel quantitative MRI protocol can reveal new aspects of structural and biochemical muscle pathology in three classic MFM subtypes. MRI of the lower legs was performed in nine MFM patients with filamin-C (FLNC; n = 5), desmin (DES, n = 2) and LIM domain binding 3 (LDB3; n = 2) gene mutations, one patient with non-MFM, filamin-C related distal myopathy (4 males, 6 females, 51.0 ± 7.7 years) and 10 age-matched healthy control subjects (5 males, 5 females, 50.0 ± 11.0 years). 1H MRI at 3 T addressed fatty replacement and edema-like changes as well as quantitative measurements of proton density fat fraction (PDFF) and water T2 relaxation times. 39K/23Na MRI at 7 T was employed to determine apparent tissue potassium and tissue sodium concentrations (aTPC/aTSC). T1-weighted and T2-weighted STIR imaging showed the highest degree of fat replacement in the soleus and gastrocnemius medialis muscle regions and the highest degree of edema-like changes in the extensor regions in all 10 myopathy patients. The lowest degree of fat replacement and edema-like changes was present in the gastrocnemius lateralis muscles. Marked fatty replacement of peroneus muscles was also present in DES-related MFM and FLNC-related distal myopathy. Muscular PDFF values were significantly increased in all MFM patients (p = 0.003 - < 0.001) with 60 and 35 of 63 muscles analysed showing increased mean PDFF (> 10% and > 50%). When excluding the muscles with PDFF > 50%, the median water T2 was significantly increased in all muscle regions of MFM patients with the exception of the tibialis anterior and posterior muscles. Fat-corrected aTSC values in MFM patients were significantly increased compared to healthy controls (55.6 ± 16.3 mM vs. 23.2 ± 5.5 mM, p < 0.001) in all muscles but peroneus muscles, whereas fat-corrected aTPC values were reduced in all muscles except for gastrocnemius lateralis, tibialis posterior and peroneus muscles (75.4 ± 13.3 mM vs. 108.9 ± 9.9 mM, p < 0.001). Quantitative PDFF measurements and water T2 mapping serve as valuable tools to objectively quantify fat and edema-like changes in MFM. Furthermore, changes in potassium/sodium ion balance in the lower leg muscles of MFM patients could serve as new markers to quantify the extent of biochemical changes in individual muscle regions. Further longitudinal evaluation is required to validate whether they are sensitive to changes prior to a high degree of fat replacement.

#4

Anaesthetic Management of a Patient With LDB3-Associated Myopathy Undergoing Prostate Biopsy Under Total Intravenous Anaesthesia: A Case Report.

Cureus2026 Feb

Mutations in the LDB3 gene are implicated in myofibrillar myopathy and cardiomyopathy. Consider cardiac conduction defects and the muscle's sensitivity to some anaesthetics when providing anaesthesia in the perioperative period. We present the anaesthetic management of a 76-year-old man with genetically confirmed LDB3 mutation who presented for prostate biopsy with a background of progressive distal myopathy, mild cardiac involvement, and normal activities of daily living (ADL), undergoing anaesthesia using total intravenous anaesthesia (TIVA) to avoid the use of volatile agents or neuromuscular blockers. In this patient with a history of LDB3-associated myopathy, the use of TIVA provided a safe and effective technique of anaesthesia, and reinforced the need for an individualised anaesthetic strategy in neuromuscular disease (NMD).

#5

The Welander TIA1 mutation dedifferentiates insulin-producing cells - reversal by a GLP-1 receptor agonist.

The Journal of biological chemistry2026 Mar 03

The RNA-binding proteins TIAR and TIA1 have been reported to affect beta cell insulin production and viability. The missense E384K TIA1 autosomal dominant mutation is known to cause Welander distal myopathy. The aim of this study was to study the effects of the TIA1 E384K mutation in human insulin-producing EndoC-βH1 cells. The prime editing technique was used to generate EndoC-βH1 cell clones with the homozygous E384K TIA1 mutation. The E384K TIA1 mutation did not affect high glucose + palmitate-induced stress granule formation and cell death. Instead, the mutated cells respired and proliferated faster than wild-type cells. This was paralleled by a higher MYC mRNA and protein level, a profoundly reduced GLP-1 receptor mRNA expression, increased expression of "disallowed" beta cell genes, a proinsulin-to-insulin processing defect, a decreased insulin content and release, a decreased PAX4/ARX mRNA ratio, and an increased glucagon production. The TIA1 mutation reduced MYC mRNA binding to TIA1. Downregulation of MYC mRNA levels normalized insulin/glucagon and PAX4/ARX mRNA ratios. Long-term treatment of TIA1-mutated cells with the GLP-1R agonist liraglutide restored insulin production and reversed beta cell dedifferentiation. It is concluded that the TIA1 E384K mutation, via increased MYC levels and cell proliferation rates, causes beta cell dedifferentiation. Thus, dysfunction of RNA-binding proteins may, at least in certain cases, contribute to the impaired insulin production observed in diabetes. A better understanding of RNA-binding protein-mediated control of beta cell differentiation, and the protective impact of GLP-1 receptor agonism, could facilitate the development of new treatment strategies in diabetes.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC349 artigos no totalmostrando 198

2026

Multi-Parametric MRI Approach at 3 T and 7 T for Assessing Skeletal Muscle Pathology in Myofibrillar Myopathies: A Pilot Study.

Journal of cachexia, sarcopenia and muscle
2026

Anaesthetic Management of a Patient With LDB3-Associated Myopathy Undergoing Prostate Biopsy Under Total Intravenous Anaesthesia: A Case Report.

Cureus
2026

The Welander TIA1 mutation dedifferentiates insulin-producing cells - reversal by a GLP-1 receptor agonist.

The Journal of biological chemistry
2026

DYSF gene variant spectrum in Arab populations across eight countries: A systematic review.

Biomolecules &amp; biomedicine
2026

Comparison of whole-body muscle imaging findings between GNE myopathy and other young adult-onset hereditary myopathies.

PloS one
2025

Hydroxyethylamine & phthalimide analogs restoring defects due to GNE dysfunction: rare disease therapeutic significance.

Molecular medicine (Cambridge, Mass.)
2025

Novel Mutations in Titin Exon 363 With Different Phenotypes Including a Founder Mutation in Eastern Europe.

European journal of neurology
2025

Clinical, pathological and genetic characteristics of GNE myopathy: a single-center observational study.

BMC musculoskeletal disorders
2025

Novel missense variants associated with GNE myopathy.

Neuromuscular disorders : NMD
2025

Welander Distal Myopathy-Associated TIA1 E384K Mutation Disrupts Stress Granule Dynamics Under Distinct Stress Conditions.

Biology
2026

A heterozygous 9q34 deletion encompassing SPTAN1 as a cause of distal myopathy.

European journal of human genetics : EJHG
2025

[The pleiotropic role of X-linked SMPX gene mutations: Exploration of mechanism from deafness to myopathy].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2025

Rare autosomal recessive hereditary sensory and autonomic neuropathy type VI in a Pakistani family caused by a novel DST variant.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

Molecular genetics and therapeutic development for GNE myopathy.

Journal of human genetics
2025

A recurrent GNE variant causing GNE myopathy in unrelated patients from Pakistan: a case series.

Journal of medical case reports
2025

KLHL9-linked distal myopathy: a second family suggesting broad phenotypic variability.

Neuromuscular disorders : NMD
2025

Welander distal myopathy-associated TIA1 mutation exacerbates P-body and stress granule dynamics concomitant with nucleolar stress under oxidative stress.

Genes &amp; diseases
2025

Tips to Design Effective Splice-Switching Antisense Oligonucleotides for Exon Skipping and Exon Inclusion.

Methods in molecular biology (Clifton, N.J.)
2025

Unexpected SLC34A3 rickets in a case of suspected distal myopathy.

Pediatric nephrology (Berlin, Germany)
2025

ZASP/LDB3-related atypical distal myopathy with subtle cardiac impairment unveiled after COVID-19 infection: a short report.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology
2025

Adult-onset distal myopathy with predominant hand involvement as a rare phenotype of plectinopathy.

Journal of neuromuscular diseases
2025

Structural variation in nebulin and its impact on phenotype and inheritance: establishing a dominant distal phenotype caused by large deletions.

European journal of human genetics : EJHG
2025

Myofibrillar Myopathy: Clinico-Genetic Spectrum From a Neuromuscular Center in South India.

Journal of clinical neuromuscular disease
2025

Long term clinical follow-up and natural history in a cohort of Italian patients with GNE myopathy: the experience of a single centre.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

Autosomal dominant distal myopathy due to p.Ser85Cys mutation in the MATR3 gene: Novel case series and literature review.

Revue neurologique
2025

Computational prediction of deleterious nonsynonymous SNPs in the CTNS gene: implications for cystinosis.

BMC genomic data
2024

An Update on Reported Variants in the Skeletal Muscle α-Actin (ACTA1) Gene.

Human mutation
2024

Estimating the Prevalence of GNE Myopathy Using Population Genetic Databases.

Human mutation
2025

Analysis of the pathogenicity of novel GNE mutations and clinical, pathological, and genetic characteristics of GNE myopathy in Chinese population.

Orphanet journal of rare diseases
2025

The MFN2 Q367H variant reveals a novel pathomechanism connected to mtDNA-mediated inflammation.

Life science alliance
2025

Prospective Dysphagia Assessment in Adult Patients With Nephropathic Cystinosis.

Muscle &amp; nerve
2025

A Case of Nebulin-Related Nemaline Myopathy With Asymmetric Distal Lower Limb Weakness.

Cureus
2025

Beyond sialylation: Exploring the multifaceted role of GNE in GNE myopathy.

Molecular genetics and metabolism
2025

Heterozygous loss-of-function variants in SPTAN1 cause an early childhood onset distal myopathy.

Genetics in medicine : official journal of the American College of Medical Genetics
2025

Nutritional status of patients with nemaline myopathy and related congenital myopathies in Finland: A pilot study.

Journal of neuromuscular diseases
2025

Ultra-Orphan drug development for GNE Myopathy: A synthetic literature review and meta-analysis.

Journal of neuromuscular diseases
2024

TTN-Related Muscular Dystrophies, LGMD, and TMD, in an Estonian Family Caused by the Finnish Founder Variant.

Neurology. Genetics
2024

Structural variation in nebulin and its implications on phenotype and inheritance: establishing a dominant distal phenotype caused by large deletions.

medRxiv : the preprint server for health sciences
2025

Clinical features, mutation spectrum and factors related to reaching molecular diagnosis in a cohort of patients with distal myopathies.

Journal of neurology
2025

Myotilin gene duplication causing late-onset myotilinopathy.

European journal of neurology
2025

[Aceneuraminic acid for distal myopathy].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica
2024

The frequent variant A57F in the GNE gene in patients from Russia has Finno-Ugric Mari origin.

Frontiers in genetics
2025

Heterozygous p62/SQSTM1 mutation and right temporal variant of frontotemporal dementia: Α case report.

Neurocase
2025

Calcium level and autophagy defect in GNE mutants of rare neuromuscular disorder.

Cell biology international
2024

Decoding the Molecular Grammar of TIA1-Dependent Stress Granules in Proteostasis and Welander Distal Myopathy Under Oxidative Stress.

Cells
2025

A pilot trial for efficacy confirmation of 6'-sialyllactose supplementation in GNE myopathy: Randomized, placebo-controlled trial.

Molecular genetics and metabolism
2024

A Novel MYH14 Variant Presenting as a New Phenotype of MYH14-Associated Neuromuscular Disorders-Clinicohistologic Findings and Review of the Literature.

Journal of clinical neuromuscular disease
2024

Variability in Disease Severity in Siblings With Homozygous Missense Variant of ADSSL1: Clinical Genetic Study and Review of Literatures.

Molecular genetics &amp; genomic medicine
2025

MYH7-related myopathies: clinical, myopathological and genotypic spectrum in a multicentre French cohort.

Journal of neurology, neurosurgery, and psychiatry
2025

Preserved Forearm and Hand Muscles and Diaphragm with Mild Cardiac and Respiratory Involvement in a Patient with GNE Myopathy Harboring Homozygous Variants in GNE (c.1807G>C, p.V603L) over Four Decades after the Onset.

Internal medicine (Tokyo, Japan)
2024

Heterozygous loss-of-function variants in SPTAN1 cause a novel early childhood onset distal myopathy with chronic neurogenic features.

medRxiv : the preprint server for health sciences
2024

Novel variants and genotype-phenotype correlation in a multicentre cohort of GNE myopathy in China.

Journal of medical genetics
2024

CGG/CCG Repeat Expansions in LOC642361/NUTM2B-AS1 in Thai Patients With Oculopharyngodistal Myopathy.

Neurology. Genetics
2024

Genomic and phenotypic landscapes of X-linked hereditary hearing loss in the Chinese population.

Orphanet journal of rare diseases
2024

GNE Myopathy: Genotype - Phenotype Correlation and Disease Progression in an Indian Cohort.

Journal of neuromuscular diseases
2024

[Clinical and genetic characterisation of hereditary distal myopathies in a series of Colombian patients].

Revista de neurologia
2024

Asymmetric scapuloperoneal phenotype of MATR3-related distal myopathy: case series.

Frontiers in genetics
2024

Diverse Phenotypic Presentation of the Welander Distal Myopathy Founder Mutation, With Myopathy and Amyotrophic Lateral Sclerosis in the Same Family.

Journal of clinical neuromuscular disease
2024

Defining the landscape of TIA1 and SQSTM1 digenic myopathy.

Neuromuscular disorders : NMD
2024

Protein-extending ACTN2 frameshift variants cause variable myopathy phenotypes by protein aggregation.

Annals of clinical and translational neurology
2024

A novel variant in the GNE gene in a Malian patient presenting with distal myopathy.

Neurogenetics
2024

Generation of iPSC lines from three Laing distal myopathy patients with a recurrent MYH7 p.Lys1617del variant.

Stem cell research
2024

Current advance on distal myopathy genetics.

Current opinion in neurology
2024

A rare form of LIM domain-binding protein 3 (LDB3) mutation causes hypertrophic cardiomyopathy and myofibrillar myopathy type 4.

Clinical genetics
2024

A novel mutation alters GNE bifunctional enzyme activity and leads to familial inherited GNE diseases.

Gene
2024

Limb Girdle Muscular Dystrophy Type 2B (LGMD2B): Diagnosis and Therapeutic Possibilities.

International journal of molecular sciences
2024

Induced Muscle and Liver Absence of Gne in Postnatal Mice Does Not Result in Structural or Functional Muscle Impairment.

Journal of neuromuscular diseases
2024

Altered autophagic flux in GNE mutant cells of Indian origin: Potential drug target for GNE myopathy.

Experimental cell research
2024

Large phenotypic diversity by genotype in patients with GNE myopathy: 10 years after the establishment of a national registry in Japan.

Journal of neurology
2024

A therapeutic leap: how myosin inhibitors moved from cardiac interventions to skeletal muscle myopathy solutions.

The Journal of clinical investigation
2024

A Laing distal myopathy-associated proline substitution in the β-myosin rod perturbs myosin cross-bridging activity.

The Journal of clinical investigation
2024

Recessive GNE Mutations in Korean Nonaka Distal Myopathy Patients with or without Peripheral Neuropathy.

Genes
2024

Axial involvement as a prominent feature in SMPX-related distal myopathy.

Neuromuscular disorders : NMD
2024

Potential small effector molecules restoring cellular defects due to sialic acid biosynthetic enzyme deficiency: Pathological relevance to GNE myopathy.

Biochemical pharmacology
2024

Pseudoexon activation by deep intronic variation in GNE myopathy with thrombocytopenia.

Muscle &amp; nerve
2024

The Dysferlinopathies Conundrum: Clinical Spectra, Disease Mechanism and Genetic Approaches for Treatments.

Biomolecules
2024

Resilience in patients and family caregivers living with congenital disorders of glycosylation (CDG): a quantitative study using the brief resilience coping scale (BRCS).

Orphanet journal of rare diseases
2023

Skeletal muscle involvement in biallelic SORD mutations: case report and review of the literature.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology
2024

Understanding pathophysiology of GNE myopathy and current progress towards drug development.

Journal of biosciences
2024

Haplotype information of large neuromuscular disease genes provided by linked-read sequencing has a potential to increase diagnostic yield.

Scientific reports
2024

Dolichocephaly, Arachnodactyly, Diplopia, and Distal Myopathy - Novel Phenotype of MICU1 Variant c.553C>T.

Cureus
2024

Myofibrillar myopathies due to a novel mutation in exon 8 of the LDB3 gene.

International journal of rheumatic diseases
2024

Growth deficiency and enhanced basal immunity in Arabidopsis thaliana mutants of EDM2, EDM3 and IBM2 are genetically interlinked.

PloS one
2024

Rare ACTN2 Frameshift Variants Resulting in Protein Extension Cause Distal Myopathy and Hypertrophic Cardiomyopathy through Protein Aggregation.

medRxiv : the preprint server for health sciences
2023

High Prevalence of a c.5979dupA Variant in the Dysferlin Gene (DYSF) in Individuals from a Semiarid Region of Brazil.

Current genomics
2024

Childhood-Onset Myopathy With Preserved Ambulation Caused by a Recurrent ADSSL1 Missense Variant.

Neurology. Genetics
2024

GNE deficiency impairs Myogenesis in C2C12 cells and cannot be rescued by ManNAc supplementation.

Glycobiology
2023

A case series of patients with filamin-C truncating variants attending a specialized cardiac genetic clinic.

European heart journal. Case reports
2024

The new missense G376V-TDP-43 variant induces late-onset distal myopathy but not amyotrophic lateral sclerosis.

Brain : a journal of neurology
2023

Evaluation of N-Acetylmannosamine Administration to Restore Sialylation in GNE-Deficient Human Embryonal Kidney Cells.

Frontiers in bioscience (Landmark edition)
2023

Distal myopathy due to digenic inheritance of TIA1 and SQSTM1 variants in two unrelated Spanish patients.

Neuromuscular disorders : NMD
2024

Titin copy number variations associated with dominant inherited phenotypes.

Journal of medical genetics
2023

Pharmacokinetics and clinical efficacy of 6'-sialyllactose in patients with GNE myopathy: Randomized pilot trial.

Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie
2023

[Efficacy of Aceneuramic Acid for Distal Myopathy with Rimmed Vacuoles].

Brain and nerve = Shinkei kenkyu no shinpo
2023

Dysferlinopathy in Tunisia: clinical spectrum, genetic background and prognostic profile.

Neuromuscular disorders : NMD
2023

MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy.

Cell reports
2023

GNE myopathy: can homozygous asymptomatic subjects give a clue for the identification of protective factors?

Neuromuscular disorders : NMD
2023

Late-onset facioscapulohumeral muscular dystrophy type 1 in previously undiagnosed families: Presenting clinical features in an often-misdiagnosed disorder.

Muscle &amp; nerve
2023

Efficacy confirmation study of aceneuramic acid administration for GNE myopathy in Japan.

Orphanet journal of rare diseases
2023

A novel in-frame deletion in MYOT causes an early adult onset distal myopathy.

Clinical genetics
2023

Hypertrophic Cardiomyopathy Complicated by Post-COVID-19 Myopericarditis in Patient with ANO5-Related Distal Myopathy.

Genes
2023

Development of Assays to Measure GNE Gene Potency and Gene Replacement in Skeletal Muscle.

Journal of neuromuscular diseases
2023

Aberrant mRNA processing caused by splicing mutations in TTN-related neuromuscular disorders.

Journal of human genetics
2023

The Arabidopsis RRM domain proteins EDM3 and IBM2 coordinate the floral transition and basal immune responses.

The Plant journal : for cell and molecular biology
2023

Metformin protects fibroblasts from patients with GNE myopathy by restoring autophagic flux via an AMPK/mTOR-independent pathway.

Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie
2023

Clinical-pathological features and muscle imaging findings in 36 Chinese patients with rimmed vacuolar myopathies: case series study and review of literature.

Frontiers in neurology
2023

Caveolinopathy: Clinical, histological, and muscle imaging features and follow-up in a multicenter retrospective cohort.

European journal of neurology
2023

 A novel variant in the tropomyosin 3 gene presenting as an adult-onset distal myopathy - a case report.

BMC neurology
2023

Phase II/III Study of Aceneuramic Acid Administration for GNE Myopathy in Japan.

Journal of neuromuscular diseases
2023

DES c.1360C>T: A Rare Desmin Variant Causing Early Distal Myopathy and Cardiomyopathy.

Cureus
2023

Autophagic vacuolar myopathy involving the phenotype of spinocerebellar ataxia type 3.

Neuropathology : official journal of the Japanese Society of Neuropathology
2023

C-terminal frameshift variant of TDP-43 with pronounced aggregation-propensity causes rimmed vacuole myopathy but not ALS/FTD.

Acta neuropathologica
2023

Frameshift mutation in SQSTM1 causes proximal myopathy with rimmed vacuoles: A case report.

Frontiers in neurology
2023

Glycation Interferes with the Activity of the Bi-Functional UDP-N-Acetylglucosamine 2-Epimerase/N-Acetyl-mannosamine Kinase (GNE).

Biomolecules
2023

Myofibrillar myopathy presenting with an inclusion body myositis-like phenotype.

Muscle &amp; nerve
2023

Zinc Alters the Supramolecular Organization of Nucleic Acid Complexes with Full-Length TIA1.

bioRxiv : the preprint server for biology
2023

MATR3 P154S knock-in mice do not exhibit motor, muscle or neuropathologic features of ALS.

Biochemical and biophysical research communications
2023

Miyoshi Muscular Dystrophy Type 1 with Mutated DYSF Gene Misdiagnosed as Becker Muscular Dystrophy: A Case Report and Literature Review.

Genes
2023

A novel phenotype of AChR-deficiency syndrome with predominant facial and distal weakness resulting from the inclusion of an evolutionary alternatively-spliced exon in CHRNA1.

Neuromuscular disorders : NMD
2022

Multidimensional analyses of the pathomechanism caused by the non-catalytic GNE variant, c.620A>T, in patients with GNE myopathy.

Scientific reports
2023

Distinctive chaperonopathy in skeletal muscle associated with the dominant variant in DNAJB4.

Acta neuropathologica
2022

Miyoshi Muscular Dystrophy Due to Novel Splice Site Variants in DYSF Gene.

Child neurology open
2023

Morpholino-Mediated Exons 28-29 Skipping of Dysferlin and Characterization of Multiexon-skipped Dysferlin using RT-PCR, Immunoblotting, and Membrane Wounding Assay.

Methods in molecular biology (Clifton, N.J.)
2022

Genetic and Clinical Spectrum of GNE Myopathy in Russia.

Genes
2023

Distal upper limb involvement in myasthenia-myositis association.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2022

Anoctamin 5 (ANO5) Muscle Disorders: A Narrative Review.

Genes
2022

[A Case of Hirayama Disease Presenting Horn Hand: Spinal Horn Hand].

Brain and nerve = Shinkei kenkyu no shinpo
2022

Mutation update for the ACTN2 gene.

Human mutation
2022

ALS mutations in the TIA-1 prion-like domain trigger highly condensed pathogenic structures.

Proceedings of the National Academy of Sciences of the United States of America
2022

Myogenesis defects in a patient-derived iPSC model of hereditary GNE myopathy.

NPJ Regenerative medicine
2022

Expanded clinical spectrum of oculopharyngodistal myopathy type 1.

Muscle &amp; nerve
2022

Recurrent, non-traumatic, non-exertional rhabdomyolysis after immunologic stimuli in a healthy adolescent female: a case report.

BMC pediatrics
2022

Dysferlinopathies: Clinical and genetic variability.

Clinical genetics
2022

A Novel Homozygous Variant in DYSF Gene Is Associated with Autosomal Recessive Limb Girdle Muscular Dystrophy R2/2B.

International journal of molecular sciences
2022

Synthesis of 2-Acetamido-1,3,4-Tri-O-Acetyl-2-Deoxy-D-Mannopyranose -6-Phosphate Prodrugs as Potential Therapeutic Agents.

Current protocols
2022

A novel nonsense mutation in the dimerization domain of FLNC causing mild myofibrillar myopathy.

Clinical neurology and neurosurgery
2022

Recent advances in establishing a cure for GNE myopathy.

Current opinion in neurology
2022

Glycogen accumulation in GNE myopathy.

Neuromuscular disorders : NMD
2022

The role of amyloid β in the pathological mechanism of GNE myopathy.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2022

Case Reports: Novel Missense Variants in the Filamin C Actin Binding Domain Cause Variable Phenotypes.

Frontiers in neurology
2022

Case Report: A Novel Splice-Site Mutation in DNAJB6 Associated With Juvenile-Onset Proximal-Distal Myopathy in a Chinese Patient.

Frontiers in genetics
2022

Expanding the Phenotypic Spectrum of Vocal Cord and Pharyngeal Weakness With Distal Myopathy due to the p.S85C MATR3 Mutation.

Neurology. Genetics
2022

Role of HSP70 chaperone in protein aggregate phenomenon of GNE mutant cells: Therapeutic lead for GNE Myopathy.

The international journal of biochemistry &amp; cell biology
2022

A 78-year-old Japanese male with late-onset PHKA1-associated distal myopathy: Case report and literature review.

Neuromuscular disorders : NMD
2022

DNAJB2 c.184C>T mutation associated with distal hereditary motor neuropathy with rimmed vacuolar myopathy.

Clinical neuropathology
2022

Longitudinal dysphagia assessment in adult patients with nephropathic cystinosis using the Modified Barium Swallow Impairment Profile.

Muscle &amp; nerve
2022

Different electrophysiology patterns in GNE myopathy.

Orphanet journal of rare diseases
2022

A novel missense HNRNPA1 variant in the PY-NLS domain in a patient with late-onset distal myopathy.

Neuromuscular disorders : NMD
2022

Tissue-specific isoform expression of GNE gene in human tissues.

Journal of muscle research and cell motility
2022

Gene analysis and clinical features of 22 GNE myopathy patients.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2022

The Role of Impaired Mitochondrial Dynamics in MFN2-Mediated Pathology.

Frontiers in cell and developmental biology
2022

Functional characterization of GNE mutations prevalent in Asian subjects with GNE myopathy, an ultra-rare neuromuscular disorder.

Biochimie
2022

Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies.

European journal of translational myology
2022

Dynamics of T-Cell Intracellular Antigen 1-Dependent Stress Granules in Proteostasis and Welander Distal Myopathy under Oxidative Stress.

Cells
2022

Molecular determinants and modifiers of Matrin-3 toxicity, condensate dynamics, and droplet morphology.

iScience
2022

Upper body involvement in GNE myopathy assessed by muscle imaging.

Neuromuscular disorders : NMD
2022

Multiple isogenic GNE-myopathy modeling with mutation specific phenotypes from human pluripotent stem cells by base editors.

Biomaterials
2022

Calpainopathy (Leyden-Mobius Limb-Girdle Muscular Dystrophy Type 2A Phenotype) and Dysferlinopathy (Miyoshi Distal Myopathy Limb-Girdle Muscular Dystrophy Type 2B Phenotype) of Preadolescent Onset: Case Reports of Two Male Filipinos.

Cureus
2022

A female carrier of spinal and bulbar muscular atrophy diagnosed with DNAJB6-related distal myopathy.

Journal of human genetics
2022

Clinical, genetic, and pathological characterization of GNE myopathy in China.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2022

A rare case of distal myopathy.

Indian journal of pathology &amp; microbiology
2022

Muscle "islands": An MRI signature distinguishing neurogenic from myopathic causes of early onset distal weakness.

Neuromuscular disorders : NMD
2022

Myopathy-associated G154S mutation causes important changes in the conformational stability, amyloidogenic properties, and chaperone-like activity of human αB-crystallin.

Biophysical chemistry
2021

A case report of deglutition triggered atrial fibrillation in a patient with Laing distal myopathy.

European heart journal. Case reports
2022

Neuromuscular conditions and the impact of cystine-depleting therapy in infantile nephropathic cystinosis: A cross-sectional analysis of 55 patients.

Journal of inherited metabolic disease
2022

Extra-muscular manifestations in GNE myopathy patients: A nationwide repository questionnaire survey in Japan.

Clinical neurology and neurosurgery
2022

Different K+-release in distal myogenic and neurogenic muscular weakness during non-ischemic exercise.

Journal of the neurological sciences
2021

Dominant Distal Myopathy 3 (MPD3) Caused by a Deletion in the HNRNPA1 Gene.

Neurology. Genetics
2021

Expanding the clinicopathological-genetic spectrum of GNE myopathy by a Chinese neuromuscular centre.

Journal of cellular and molecular medicine
2021

First Family of MATR3-Related Distal Myopathy From Italy: The Role of Muscle Biopsy in the Diagnosis and Characterization of a Still Poorly Understood Disease.

Frontiers in neurology
2021

Clinicopathological features of titinopathy from a Chinese neuromuscular center.

Neuropathology : official journal of the Japanese Society of Neuropathology
2022

Visualizing Muscle Sialic Acid Expression in the GNED207VTgGne-/- Cmah-/- Model of GNE Myopathy: A Comparison of Dietary and Gene Therapy Approaches.

Journal of neuromuscular diseases
2021

Out-of-Frame Mutations in ACTN2 Last Exon Cause a Dominant Distal Myopathy With Facial Weakness.

Neurology. Genetics
2021

Thigh and Leg Muscle MRI Findings in GNE Myopathy.

Journal of neuromuscular diseases
2021

A novel TTN variant in a patient with distal myopathy of lower limbs and dilated cardiomyopathy.

Neurologia
2021

Cybernic treatment with wearable cyborg Hybrid Assistive Limb (HAL) improves ambulatory function in patients with slowly progressive rare neuromuscular diseases: a multicentre, randomised, controlled crossover trial for efficacy and safety (NCY-3001).

Orphanet journal of rare diseases
2021

A novel frameshift ACTN2 variant causes a rare adult-onset distal myopathy with multi-minicores.

CNS neuroscience &amp; therapeutics
2021

Functional recovery of a novel knockin mouse model of dysferlinopathy by readthrough of nonsense mutation.

Molecular therapy. Methods &amp; clinical development
2021

MYH7-related disorders in two Bulgarian families: Novel variants in the same region associated with different clinical manifestation and disease penetrance.

Neuromuscular disorders : NMD
2021

Clinicopathologic Features of Oculopharyngodistal Myopathy With LRP12 CGG Repeat Expansions Compared With Other Oculopharyngodistal Myopathy Subtypes.

JAMA neurology
2021

Missense mutations in small muscle protein X-linked (SMPX) cause distal myopathy with protein inclusions.

Acta neuropathologica
2021

Congenital asymmetric distal myopathy with hemifacial weakness caused by a heterozygous large de novo mosaic deletion in nebulin.

Neuromuscular disorders : NMD
2021

A novel deletion in the C-terminal region of HSPB8 in a family with rimmed vacuolar myopathy.

Journal of human genetics
2021

Neuromuscular disease: 2021 update.

Free neuropathology
2021

Results from a 3-year Non-interventional, Observational Disease Monitoring Program in Adults with GNE Myopathy.

Journal of neuromuscular diseases
2020

Panorama of the distal myopathies.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology
2020

Late-onset myopathies: clinical features and diagnosis.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology
2021

Matrin 3 in neuromuscular disease: physiology and pathophysiology.

JCI insight
2021

Mutational Spectrum of CAPN3 with Genotype-Phenotype Correlations in Limb Girdle Muscular Dystrophy Type 2A/R1 (LGMD2A/LGMDR1) Patients in India.

Journal of neuromuscular diseases
2020

Impaired Autophagy in Retinal Pigment Epithelial Cells Induced from iPS Cell of Distal Myopathy with Rimmed Vacuole Patient.

The Tokai journal of experimental and clinical medicine
2020

Clinical features and genotypes of Laing distal myopathy in a group of Chinese patients, with in-frame deletions of MYH7 as common mutations.

Orphanet journal of rare diseases
2021

Skeletal Muscle Magnetic Resonance Biomarkers in GNE Myopathy.

Neurology
2020

GNE Myopathy as a Myofibrillar Myopathy: Potential Important Disease Mechanism Implied by Muscle Biopsy.

Journal of clinical neuromuscular disease
2021

Early and consistent pattern of proximal weakness in GNE myopathy.

Muscle &amp; nerve
2020

Ryanodine receptor 1-related disorders: an historical perspective and proposal for a unified nomenclature.

Skeletal muscle
2021

A study of the phenotypic variability and disease progression in Laing myopathy through the evaluation of muscle imaging.

European journal of neurology
2021

Motor axonal neuropathy associated with GNE mutations.

Muscle &amp; nerve
2020

Expanding the Clinico-Genetic Spectrum of Myofibrillar Myopathy: Experience From a Chinese Neuromuscular Center.

Frontiers in neurology
Ver todos os 349 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Miopatia distal.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Miopatia distal

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Comparison of whole-body muscle imaging findings between GNE myopathy and other young adult-onset hereditary myopathies.
    PloS one· 2026· PMID 41575995mais citado
  2. A heterozygous 9q34 deletion encompassing SPTAN1 as a cause of distal myopathy.
    European journal of human genetics : EJHG· 2026· PMID 40999194mais citado
  3. Multi-Parametric MRI Approach at 3&#x2009;T and 7&#x2009;T for Assessing Skeletal Muscle Pathology in Myofibrillar Myopathies: A Pilot Study.
    Journal of cachexia, sarcopenia and muscle· 2026· PMID 41854206mais citado
  4. Anaesthetic Management of a Patient With LDB3-Associated Myopathy Undergoing Prostate Biopsy Under Total Intravenous Anaesthesia: A Case Report.
    Cureus· 2026· PMID 41798484mais citado
  5. The Welander TIA1 mutation dedifferentiates insulin-producing cells - reversal by a GLP-1 receptor agonist.
    The Journal of biological chemistry· 2026· PMID 41786146mais citado
  6. Dysferlinopathies: phenotypic study of a Moroccan series of 28 cases.
    Acta Myol· 2026· PMID 41954144recente
  7. Phenotypic characterization of dominantly inherited distal nebulin myopathy.
    Neuromuscul Disord· 2026· PMID 41886871recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:599(Orphanet)
  2. MONDO:0018949(MONDO)
  3. GARD:18699(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q5282843(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Miopatia distal
Compêndio · Raras BR

Miopatia distal

ORPHA:599 · MONDO:0018949
Prevalência
1-9 / 1 000 000
Herança
Autosomal dominant, Autosomal recessive
CID-11
Ensaios
1 ativos
Medicamentos
1 registrados
Início
All ages
Prevalência
0.33 (United Kingdom)
MedGen
UMLS
C0751336
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades